Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Valemetostat + Trastuzumab Deruxtecan for Breast Cancer
Recruiting1 awardPhase 1
Houston, Texas
This trial is testing a new drug called valemetostat with an existing drug, trastuzumab deruxtecan, for patients with a specific type of breast cancer that doesn't respond well to usual treatments. The combination aims to stop cancer cell growth and deliver chemotherapy directly to the cancer cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service